Back to search

High-dose cytosine arabinoside in the treatment of refractory acute nonlymphocytic leukemia in adults: Results of two six-day regimens

Data up to Jan 2025

Published1982
Citations15
References15

Total Citations Per Year

Abstract

References (15)

Arabinosyl Cytosine: A Useful Agent in the Treatment of Acute Leukemia in Adults

1968 • 559 citations

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

1979 • 290 citations

HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIA

1977 • 218 citations

Treatment of Acute Myelogenous Leukemia in Children and Adults

1980 • 218 citations

Central nervous system toxicity of high-dose systemic cytosine arabinoside

1981 • 204 citations

Treatment of acute nonlymphocytic leukemia: use of anthracycline- cytosine arabinoside induction therapy and comparison of two maintenance regimens

1979 • 153 citations

Treatment of acute nonlymphocytic leukemia: use of anthracycline- cytosine arabinoside induction therapy and comparison of two maintenance regimens

1979 • 115 citations

DAUNORUBICIN IN THE TREATMENT OF ACUTE MYELOCYTIC LEUKÆMIA

1969 • 113 citations

Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia

1975 • 85 citations

Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response

1974 • 77 citations

Chemotherapy of Acute Leukemia

1974 • 67 citations

Prolonged infusion of arabinosyl cytosine in childhood leukemia

1970 • 65 citations

Progress in the Treatment of Adults With Acute Leukemia

1976 • 64 citations

Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia

1980 • 58 citations

Cytarabine for Acute Leukemia in Adults

1974 • 44 citations

Cited By (0)

Loading...
High-dose cytosine arabinoside in the treatment of refractory acute nonlymphocytic… (1982) – Medical and Pediatric Oncology | Metascience Observatory Explorer